["{\n\"step_by_step_thinking\": \"The relevant documents describe the natural history of Parkinson's disease, including its slow progression over several decades. The document on slowing of EEG in Parkinson's disease shows that Parkinsonian patients with dementia have distinctly slower EEGs than those without dementia. There is no direct information about Isradipine and its effect on the progression of early Parkinson Disease. However, the MIS study mentions that Isradipine was used to treat hypertension, but there is no mention of its use in treating Parkinson's disease. The [Current therapeutic approach in Parkinson disease] document discusses new approaches for slowing down the progression of the disease, including treatments aimed at decreasing motor side effects, but does not specifically mention Isradipine.\",\n\"answer_choice\": \"B\""]